| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 206.97B | 206.13B | 207.35B | 191.25B | 164.47B | 150.41B |
| Gross Profit | 30.26B | 28.65B | 29.79B | 22.83B | 23.47B | 21.13B |
| EBITDA | 34.92B | 34.32B | 45.91B | 32.51B | 31.62B | 26.11B |
| Net Income | 12.53B | 13.22B | 16.97B | 9.30B | 9.80B | 7.98B |
Balance Sheet | ||||||
| Total Assets | 289.17B | 291.42B | 292.45B | 258.06B | 245.44B | 225.53B |
| Cash, Cash Equivalents and Short-Term Investments | 39.88B | 35.61B | 45.12B | 32.09B | 27.01B | 28.33B |
| Total Debt | 60.13B | 69.89B | 64.45B | 63.58B | 64.63B | 67.48B |
| Total Liabilities | 122.09B | 123.67B | 125.06B | 119.33B | 115.06B | 113.02B |
| Stockholders Equity | 166.00B | 166.69B | 166.41B | 137.82B | 129.63B | 111.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.12B | 736.00M | 7.68B | 1.47B | 8.57B |
| Operating Cash Flow | 0.00 | 23.43B | 35.38B | 24.13B | 18.32B | 26.99B |
| Investing Cash Flow | 0.00 | -23.40B | -19.58B | -16.43B | -17.19B | -18.51B |
| Financing Cash Flow | 0.00 | -10.16B | -4.66B | -3.51B | -4.06B | 808.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥430.60B | 6.79 | 8.36% | 2.71% | 0.75% | 35.26% | |
79 Outperform | ¥440.70B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
75 Outperform | ¥499.02B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
67 Neutral | ¥182.65B | 8.40 | ― | 1.03% | 3.62% | 3.64% | |
67 Neutral | ¥5.32T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥1.69T | 14.23 | 8.34% | 2.03% | 4.33% | 524.86% |